Avinger Inc. (AVGR): Kapitalisasi marang pendapatan
Avinger, Inc. management is betting on the development of innovative laser systems for vascular therapy. Consistent sales of surgical consumables create a steady cash flow and support margins. However, the aggressive promotion of these systems is leading to a temporary liquidity shortage. The estimated price-to-sales ratio reflects the market valuation of the business, with this metric equal to 0.20.
Rincian analitis perusahaan Avinger, Inc (AVGR)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Avinger, Inc.|AVGR - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Avinger Inc|AVGR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Avinger, Inc|AVGR - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Avinger|Rasio jangkoan perantara avinger.com
- data bathi lan kelipatan valuasi:
AVGR - Bathi resik|Bathi resik sing dikarepake Avinger, Inc.|AVGR - Rasio rega marang bathi|Pangali forward rega marang bathi Avinger Inc.|AVGR - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Avinger, Inc|AVGR - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Avinger|AVGR - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan avinger.com|AVGR - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Avinger, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:AVGR avinger.com
For Avinger, Inc., whose model is based on recurring sales of vascular surgery consumables, the current P/S valuation of 0.20 reflects market confidence in revenue stability. This multiple compares market capitalization to sales volume, allowing investors to identify any imbalance in the asset's value relative to its ability to generate cash flow.
Pesaing Avinger, Inc.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS - Kapitalisasi marang pendapatan|Multiplikator P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corporation)|Rasio rega marang pendapatan Sensus Healthcare Corp|Kapitalisasi marang pendapatan Zynex Corp (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan Inspira Technologies IINN|ICU: Rasio kapitalisasi marang pendapatan|IRIX: Kapitalisasi marang pendapatan|Intelligent Bio Solutions - Kapitalisasi marang volume dodolan|XAIR: Multiplikator P/S|profusa.com (PFSA) - Multiplikator P/S|Kapitalisasi marang pendapatan SSKN|Rasio rega marang pendapatan GCTK|Multiplikator P/S NAOV|Koefisien rega marang pendapatan Venus Concept Corporation|Rasio rega marang pendapatan Nuwellis, Inc. NUWE|AEMD: Rasio kapitalisasi marang pendapatan|TransEnterix - Multiplikator P/S|Multiplikator rega marang pendapatan BioSig (BSGM)|CUTR: Multiplikator P/S|Rega marang dodolan Know Labs Corporation (KNW)|Rasio rega marang pendapatan Inari Medical, Inc.|NVRO: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan
